Back to today’s briefing

Story perspectives

FDA Warning Removal Sparks 162% Estrogen Patch Shortage

6/29/2026

31 7 Full Breakdown

Summary

Story summary

Demand for estrogen patches rose 162% over two years, creating a supply gap of at least one year.
The FDA removed a black-box warning on hormone replacement therapy last fall, spurring the surge.
Manufacturers cannot meet nationwide demand, causing a shortage across the United States.
Hers reported prescriptions more than doubled from 594,000 in June 2024 to 1.6 million in May 2026.

1 of 1

Story summary

Demand for estrogen patches rose 162% over two years, creating a supply gap of at least one year.
The FDA removed a black-box warning on hormone replacement therapy last fall, spurring the surge.
Manufacturers cannot meet nationwide demand, causing a shortage across the United States.
Hers reported prescriptions more than doubled from 594,000 in June 2024 to 1.6 million in May 2026.